Willemien C Menke-van der Houven van Oordt

22PUBLICATIONS
124CO-AUTHORS
Molecular targetsPredictive and prognostic markersVeterinary diagnosis and diagnosticsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 06, 2026
OncoMimic peptide-based immunotherapy EO2401 induces shared T cell clusters in patients with adrenal cancer.

|May 04, 2026
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer.

|Nov 10, 2025
Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer.

Sophie L Gerritse, Erik J van Helden, Anne I J Arens

|Mar 04, 2025
The Diagnostic Accuracy of 18F-FDG PET and 18F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast Cancer.

Jelijn J Knip, Ramsha Iqbal, Emma C Bonjer

|Oct 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Mattia Rediti, Danai Fimereli, Magdalena Mileva

|Jul 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancer.

Niels E Wondergem, Iris H C Miedema, Rieneke van de Ven

Pageof 4

Frequent Collaborators

5 joint publications

Gerben J C Zwezerijnen

4 joint publications

Carolina P Schröder

4 joint publications

Andor W J M Glaudemans

4 joint publications

Iris H C Miedema